Literature DB >> 12642630

Expression of the LIM proteins paxillin and Hic-5 in human tissues.

Tsutomu Yuminamochi1, Yutaka Yatomi, Makoto Osada, Tsukasa Ohmori, Yoshio Ishii, Kumiko Nakazawa, Shigemi Hosogaya, Yukio Ozaki.   

Abstract

The LIM domain is a protein-protein interaction motif critically involved in a variety of fundamental biological processes, including cytoskeletal organization, cell lineage specification, and organ development. In this study we examined the expression of the LIM proteins paxillin and Hic-5 in adult human tissues by immunohistochemistry and immunoblotting. Paxillin expression was widespread and observed both in non-muscle and muscle tissues. Of the latter, paxillin was mainly expressed in multinuclear striated muscle. In contrast, Hic-5 showed restricted expression and was expressed in muscle tissues, mainly in mononuclear smooth muscle. Taken together with previous findings, it appears likely that the counterbalance between paxillin and Hic-5 may be deeply involved in muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642630     DOI: 10.1177/002215540305100413

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  23 in total

Review 1.  Non-receptor tyrosine kinases and the actin cytoskeleton in contractile vascular smooth muscle.

Authors:  Jacqueline Ohanian; Maria Pieri; Vasken Ohanian
Journal:  J Physiol       Date:  2014-12-23       Impact factor: 5.182

2.  Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation.

Authors:  Scott D Varney; Courtney B Betts; Rui Zheng; Lei Wu; Boris Hinz; Jiliang Zhou; Livingston Van De Water
Journal:  J Cell Sci       Date:  2016-01-12       Impact factor: 5.285

3.  Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein.

Authors:  Xiaobo Wang; Guoqing Hu; Courtney Betts; Erin Yund Harmon; Rebecca S Keller; Livingston Van De Water; Jiliang Zhou
Journal:  J Biol Chem       Date:  2011-10-08       Impact factor: 5.157

4.  Expression of focal adhesion proteins in the developing rat kidney.

Authors:  Sato Matsuura; Shuji Kondo; Kenichi Suga; Yukiko Kinoshita; Maki Urushihara; Shoji Kagami
Journal:  J Histochem Cytochem       Date:  2011-06-24       Impact factor: 2.479

5.  Selective coregulator function and restriction of steroid receptor chromatin occupancy by Hic-5.

Authors:  Rajas Chodankar; Dai-Ying Wu; Daniel S Gerke; Michael R Stallcup
Journal:  Mol Endocrinol       Date:  2015-03-12

6.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

7.  Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.

Authors:  Silke Kaulfuss; Michal Grzmil; Bernhard Hemmerlein; Paul Thelen; Stefan Schweyer; Jürgen Neesen; Lukas Bubendorf; Andrew G Glass; Hubertus Jarry; Bernd Auber; Peter Burfeind
Journal:  Mol Endocrinol       Date:  2008-05-01

8.  Focal adhesion components are essential for mammalian cell cytokinesis.

Authors:  Sasha H Shafikhani; Keith Mostov; Joanne Engel
Journal:  Cell Cycle       Date:  2008-09-25       Impact factor: 4.534

9.  The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis.

Authors:  Lusine Aghajanova; Michael C Velarde; Linda C Giudice
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

10.  Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity.

Authors:  Christopher A Jones; Naoyuki Nishiya; Nyall R London; Weiquan Zhu; Lise K Sorensen; Aubrey C Chan; Chinten J Lim; Haoyu Chen; Qisheng Zhang; Peter G Schultz; Alaa M Hayallah; Kirk R Thomas; Michael Famulok; Kang Zhang; Mark H Ginsberg; Dean Y Li
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.